Treatment of paragangliomas with radiation therapy
Otolaryngologic Clinics of North America, ISSN: 0030-6665, Vol: 34, Issue: 5, Page: 1007-1020
2001
- 26Citations
- 28Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations26
- Citation Indexes26
- 26
- CrossRef23
- Captures28
- Readers28
- 28
Article Description
Paragangliomas of the head and neck may be treated successfully with surgery, radiotherapy, or stereotactic radiosurgery, depending on the extent of the disease and the medical condition of the patient. The likelihood of cure is high, and there seems to be no significant difference between the treatment modalities in terms of tumor control. Surgery and radiotherapy have long track records; the data supporting stereotactic radiosurgery are limited, and the follow-up is short. Potential disadvantages of stereotactic radiosurgery are the possibility marginal miss of a tumor with a high likelihood of cure with moderate-dose fractionated radiotherapy and an increased risk of cranial neuropathy because of the large single dose of radiotherapy given with stereotactic radiosurgery. The authors treat patients with apparently completely resectable limited lesions, and in good medical condition, with surgery. Patients with more advanced tumors, those in poor medical condition, and those with tumors that recur after previous surgeries are treated with radiotherapy. The occasional patient with a limited tumor who is not a surgical candidate and cannot undergo a course of fractionated radiosurgery is considered for stereotactic radiosurgery.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0030666505703601; http://dx.doi.org/10.1016/s0030-6665(05)70360-1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034783223&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/11557452; http://linkinghub.elsevier.com/retrieve/pii/S0030666505703601; http://api.elsevier.com/content/article/PII:S0030666505703601?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0030666505703601?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0030666505703601; http://dx.doi.org/10.1016/s0030-6665%2805%2970360-1; https://dx.doi.org/10.1016/s0030-6665%2805%2970360-1
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know